Douglas R. Vogus
Douglas R. Vogus
Harvard (Postdoc, SEAS), UCSB (PhD, Chem Eng), Bucknell (BS, Chem Eng)
Verified email at g.harvard.edu
Title
Cited by
Cited by
Year
Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting
AC Anselmo, M Zhang, S Kumar, DR Vogus, S Menegatti, ME Helgeson, ...
ACS nano 9 (3), 3169-3177, 2015
3492015
Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries
AC Anselmo, CL Modery-Pawlowski, S Menegatti, S Kumar, DR Vogus, ...
ACS nano 8 (11), 11243-11253, 2014
2322014
Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid
KM Camacho, S Kumar, S Menegatti, DR Vogus, AC Anselmo, ...
Journal of Controlled Release 210, 198-207, 2015
852015
Using bulk convection in a microtensiometer to approach kinetic-limited surfactant dynamics at fluid–fluid interfaces
NJ Alvarez, DR Vogus, LM Walker, SL Anna
Journal of colloid and interface science 372 (1), 183-191, 2012
642012
A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
DR Vogus, MA Evans, A Pusuluri, A Barajas, M Zhang, V Krishnan, ...
Journal of Controlled Release 267, 191-202, 2017
512017
DAFODIL: a novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy
KM Camacho, S Menegatti, DR Vogus, A Pusuluri, Z Fuchs, M Jarvis, ...
Journal of Controlled Release 229, 154-162, 2016
492016
A review on engineering polymer drug conjugates to improve combination chemotherapy
DR Vogus, V Krishnan, S Mitragotri
Current opinion in colloid & interface science 31, 75-85, 2017
482017
Treating tumors at low drug doses using an aptamer–peptide synergistic drug conjugate
A Pusuluri, V Krishnan, V Lensch, A Sarode, E Bunyan, DR Vogus, ...
Angewandte Chemie International Edition 58 (5), 1437-1441, 2019
292019
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro‐in vivo correlation
DR Vogus, A Pusuluri, R Chen, S Mitragotri
Bioengineering & translational medicine 3 (1), 49-57, 2018
202018
Design principles of drug combinations for chemotherapy
D Wu, A Pusuluri, D Vogus, V Krishnan, CW Shields IV, J Kim, A Razmi, ...
Journal of Controlled Release 323, 36-46, 2020
182020
Measuring concentration fields in microfluidic channels in situ with a Fabry–Perot interferometer
DR Vogus, V Mansard, MV Rapp, TM Squires
Lab on a Chip 15 (7), 1689-1696, 2015
142015
Programmable Delivery of Synergistic Cancer Drug Combinations Using Bicompartmental Nanoparticles
JV Gregory, DR Vogus, A Barajas, MA Cadena, S Mitragotri, J Lahann
Advanced Healthcare Materials 9 (21), 2000564, 2020
42020
Hyaluronic acid conjugates for topical treatment of skin cancer lesions
V Krishnan, K Peng, A Sarode, S Prakash, Z Zhao, SK Filippov, ...
Science Advances 7 (24), eabe6627, 2021
12021
Polymer-drug conjugates for combination anticancer therapy
KM Camacho, S Menegatti, S Kumar, D Vogus, S Mitragotri
US Patent 10,653,789, 2020
12020
Design strategies for engineering soluto-inertial suspension interactions
A Banerjee, DR Vogus, TM Squires
Physical Review E 100 (5), 052603, 2019
12019
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
D Wu, D Vogus, V Krishnan, M Broto, A Pusuluri, Z Zhao, N Kapate, ...
Pharmaceutics 13 (1), 107, 2021
2021
Polymer-drug conjugates for combination anticancer therapy
KM Camacho, S Menegatti, S Kumar, D Vogus, S Mitragotri
US Patent App. 16/846,707, 2020
2020
Polymeric vehicles for the optimal delivery of synergistic chemotherapeutics
DR Vogus
University of California, Santa Barbara, 2017
2017
Injectable hyaluronic acid hydrogels encapsulating drug nanocrystals for long‐term treatment of inflammatory arthritis
Y Gao, D Vogus, Z Zhao, W He, V Krishnan, J Kim, Y Shi, A Sarode, ...
Bioengineering & Translational Medicine, 0
The system can't perform the operation now. Try again later.
Articles 1–19